The raised guidance and accelerating member growth signal improving fundamentals. However, EPS still negative and cash burn continues; watch for sustained operating leverage in upcoming quarters. The stock may react positively to the revenue beat and guidance raise, but historical T+20 performance on bullish calls has been weak, suggesting potential profit-taking after initial pop.
Price Chart
Executive Summary
Omada Health reports Q1 2026 revenue of $78M (+42% YoY), beating consensus of $74.1M, but GAAP EPS of -$0.05 missed the -$0.04 estimate. The company raised full-year revenue guidance to $322-$330M and adjusted EBITDA guidance to $14-$20M, both above prior outlook. Strong member growth (1.02M, +51% YoY) and expanded PBM partnerships support the bullish outlook.
Key Financial Metrics
Key Facts
- Revenue $78.048M, up 42% YoY, beat consensus of $74.1M
- GAAP net loss narrowed to $2.97M from $9.45M YoY; EPS -$0.05 vs -$1.15
- Total members surpassed 1 million, up 51% YoY
- FY2026 revenue guidance raised to $322-$330M (prior $312-$322M)
- FY2026 adjusted EBITDA guidance raised to $14-$20M (prior $7-$15M)
- New partnerships with Optum Rx and Lilly Employer Connect program
- Gross margin improved to 62% from 58% YoY
- Adjusted EBITDA turned positive: $1M vs -$4M YoY
Financial Impact
Revenue beat of $3.95M (5.3%) and guidance raise of ~$9M at midpoint
Risk Factors
- EPS miss vs consensus despite revenue beat
- Negative free cash flow of -$13.4M in Q1
- High dependency on GLP-1 program adoption and PBM relationships
- History of weak T+20 stock performance after bullish earnings reports
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-032063 |
| Document: omda-20260507.htm | 0001628280-26-032063 |
| Document: 0001628280-26-032063-index-headers.html | 0001628280-26-032063 |
| Document: 0001628280-26-032063-index.html | 0001628280-26-032063 |
| Document: 0001628280-26-032063.txt | 0001628280-26-032063 |
| 8-K Data (Synthetic) | 0001628280-26-032063 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | Insider Cluster | $20.50 $20.61 | ▼ −0.54% | ▼ −0.43% | $20.65 (−0.73%) |
Sep 4, 2026 28d ago | Insider Cluster | $22.77 $20.50 | ▲ +9.97% | ▲ +8.76% | $20.65 (+9.31%) |
Sep 3, 2026 28d ago | Insider Cluster | $22.77 $20.50 | ▼ −9.97% | ▼ −8.76% | $20.65 (−9.31%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.84 $24.47 | ▲ +2.64% | ▲ +3.09% | $20.65 (−13.38%) |
Jul 23, 2026 10w ago | Press Release | $21.20 $19.69 | ▲ +7.12% | ▲ +7.60% | $20.65 (+2.59%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.55 $23.67 | ▼ −0.51% | ▼ −0.64% | $20.65 (+12.31%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.55 $23.67 | ▲ +0.51% | ▲ +0.64% | $20.65 (−12.31%) |
Jul 6, 2026 12w ago | Insider Cluster | $22.85 $23.28 | ▼ −1.88% | ▼ −1.39% | $20.65 (+9.63%) |
Jul 6, 2026 12w ago | Insider Cluster | $22.85 $23.28 | ▲ +1.88% | ▲ +1.39% | $20.65 (−9.63%) |
Jul 3, 2026 13w ago | Insider Cluster | $22.39 $23.55 | ▼ −5.18% | ▼ −4.25% | $20.65 (+7.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access